Company Filing History:
1 out of 712 
1 out of 1 
1 out of 3,923 
Years Active: 2012-2022
Title: Arnaud Lacoste: Innovator in Pharmaceutical Compounds
Introduction
Arnaud Lacoste is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceutical compounds, holding a total of 3 patents. His work focuses on innovative methods and compounds that have potential therapeutic applications.
Latest Patents
One of his latest patents is titled "6-6 Fused Bicyclic Heteroaryl Compounds and Their Use as LATS Inhibitors." This invention relates to specific compounds and their use in inhibiting LATS, along with methods for their preparation and medical applications. Another significant patent is "Enhanced PiggyBac Transposon and Methods for Transposon Mutagenesis." This patent provides enhanced transposons and transposases that facilitate the introduction and removal of DNA inserts in host cell genomes, along with associated methods and kits.
Career Highlights
Arnaud Lacoste has worked with prestigious institutions such as The Rockefeller University and Inseron, Inc. His research has contributed to advancements in genetic engineering and pharmaceutical development.
Collaborations
He has collaborated with notable colleagues, including Ali Brivanlou and Neptune Mizrahi, further enhancing the impact of his work in the scientific community.
Conclusion
Arnaud Lacoste's innovative contributions to pharmaceutical compounds and genetic engineering highlight his role as a significant inventor in the field. His patents reflect a commitment to advancing medical science and improving therapeutic methods.